Marc Verstraete
About
In The Last Decade
Marc Verstraete
120 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 116
- Cardiology and Cardiovascular Medicine 1.1k
- Surgery 828
- Internal Medicine 778
- Hematology 651
- Pulmonary and Respiratory Medicine 615
Countries citing papers authored by Marc Verstraete
This map shows the geographic impact of Marc Verstraete's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Verstraete with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Verstraete more than expected).
Fields of papers citing papers by Marc Verstraete
This network shows the impact of papers produced by Marc Verstraete. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Verstraete. The network helps show where Marc Verstraete may publish in the future.
Co-authorship network of co-authors of Marc Verstraete
This figure shows the co-authorship network connecting the top 25 collaborators of Marc Verstraete. A scholar is included among the top collaborators of Marc Verstraete based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Verstraete. Marc Verstraete is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Thrombolysis in the management of lower limb peripheral arterial occlusion - a consensus document | 112 |
| 2 | Les promesses des antithrombotiques | 1 |
| 3 | Efficacy and safety of ridogrel versus aspirin in coronary thrombolysis with alteplase for myocardial infarction | 2 |
| 4 | The physiological inhibitors of blood coagulation and fibrinolysis | 32 |
| 5 | Coronary atherosclerosis and thrombosis | 1 |
| 6 | Lack of platelet response to collagen associated with an autoantibody against glycoprotein-ia | 1 |
| 7 | Neuere Etnwicklungen in der Fibrinolyse | 31 |
| 8 | Intravenous rt-PA for acute myocardial infarction: which patients benefit most? | 1 |
| 9 | Vergleichende randomisierte Untersuchung zur Wirksamkeit von rekombinanten Gewebe-Plasminogen-Aktivator i.v. un Streptokinase i.v. bei Patienten mit akutem Herzinfarkt | 1 |
| 10 | Influence of products of the cyclo-oxygenase pathway on platelet shape change | 4 |
| 11 | Neurogene claudicatio intermittens | 0 |
| 12 | Clinical ineffectiveness of intra-arterial or intra-venous infusions of epoprostenol in patients with peripheral obliterative disease, Stage III to IV | 4 |
| 13 | Blood changes and enhanced thromboxane-b2 and 6-keto prostaglandin production in acute plasmodium-bergei infection in hamsters | 2 |
| 14 | Dipyridamole inhibits platelet-aggregation in whole-blood invitro and exvivo | 2 |
| 15 | Manipulation of the local thromboxane and prostacyclin balance invivo by anti-thrombotic compounds | 3 |
| 16 | Metabolism of iodine labeled plasminogen and prothrombin in cirrhosis of the liver | 5 |
| 17 | The feasibility of adequate thrombolytic therapy with streptokinase in peripheral arterial occlusions | 7 |
| 18 | L'influence d'un dérivé du niacin sur le système fibrinolytique de l'homme | 1 |
| 19 | Enhancing the fibrinolytic activity in human blood by occlusion of blood vessels | 9 |
| 20 | Evaluation of prothrombin times performed with different thromboplastins | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.